MedTrace Logo

Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy

NCT02369939 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2017-08-11

No results posted yet for this study

Summary

Randomized study to investigate the efficacy of deep regional hyperthermia in patients with anal carcinoma treated by standard radiochemotherapy with MMC and 5-FU.

Conditions

  • Anal Carcinoma

Interventions

RADIATION

Irradiation

Radiotherapy 55,8 Gy - 59,4 Gy

DRUG

Mitomycin C

MMC w1, w5

DRUG

5-Fluorouracil

5-FU w1, w5

PROCEDURE

Hyperthermia

6x deep regional hyperthermia

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Rainer Fietkau, Prof. Dr. · Universitätsklinikum Erlangen, Strahlenklinik

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-12-31
Completion
2021-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02369939 on ClinicalTrials.gov